Prediction of a clinically effective dose of THY1773, a novel V (1B) receptor antagonist, based on preclinical data

por Inatani, Shoko, Mizuno‐Yasuhira, Akiko, Kamiya, Makoto, Nishino, Izumi, Sabia, Helene D., Endo, Hiromi
Publicado 2021

Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials

por Inoue, Yuichi, Uchiyama, Makoto, Umeuchi, Hideo, Onishi, Koichi, Ogo, Hiroki, Kitajima, Iwao, Matsushita, Isao, Nishino, Izumi, Uchimura, Naohisa
Publicado 2022

Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hypera...

por Saito, Takuya, Yamashita, Yushiro, Tomoda, Akemi, Okada, Takashi, Umeuchi, Hideo, Iwamori, Saki, Shinoda, Satoru, Mizuno-Yasuhira, Akiko, Urano, Hidetoshi, Nishino, Izumi, Saito, Kazuhiko
Publicado 2020